BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gendux AB 

Högbergsgatan 32

Stockholm    SE-116 20  Sweden
Phone: 46-8-556-091-89 Fax: 46-8-442-72-39


SEARCH JOBS





Segment
Gene Therapy





 Company News
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the European Medicines Evaluation Agency 11/27/2007 12:11:41 PM    More...
Introgen Therapeutics, Inc. (INGN) and Gendux Submit First Marketing Authorization Application for ADVEXIN 11/13/2007 10:31:19 AM    More...
Introgen Therapeutics, Inc. (INGN) And Gendux Announce Agreement With European Medicines Agency To File For ADVEXIN Approval Under Exceptional Circumstance Rules 10/31/2006 11:31:56 AM    More...
Introgen Therapeutics, Inc. (INGN) And Gendux Announce Orphan Designation For ADVEXIN Therapy In European Union 9/7/2006 1:49:04 PM    More...